Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$38.0M
-3.4% from 2023
Prescriptions
512
$74,220.44 per claim
Patients
59
67 prescribers
Total spending, 2024
$38.0M
$644,082.45 per patient
Medicare prescription drug plans paid $38.0M for Procysbi in 2024, for 512 prescriptions and refills to 59 patients (down 3.4% from 2023). The average cost per claim was $74,220.44.
Texas had the highest Medicare cost for Procysbi in 2024: $3.7M for 45 claims, followed by Georgia ($3.7M).
Laurence Greenbaum, pediatric medicine in Atlanta, GA, had the highest Medicare cost for Procysbi in 2024: 44 claims costing $3.7M.
Procysbi is made by Amgen Inc. (AMGN), listed in the Medicare spending data as Horizon/Amgen.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Laurence Greenbaum Atlanta, GA | Pediatric Medicine | 44 | Under 11 | $3.7M |
| Paul C Grimm Palo Alto, CA | Nephrology | 22 | Under 11 | $2.0M |
| Brent W Miller |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 78 | 616 | 63 | $43.3M |
| 2023 | 63 | 531 | 57 | $39.3M |
| 2024 | 67 | 512 | 59 | $38.0M |
Spending by manufacturer as listed in the spending data
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Nephrology |
| 28 |
| Under 11 |
| $1.9M |
| Timothy M Curley Chesapeake, VA | Nephrology | 26 | Under 11 | $1.6M |
| Chester B Whitley Minneapolis, MN | Pediatric Medicine | 16 | Under 11 | $1.4M |
| Daniel F Walton Scottsdale, AZ | Nephrology | 12 | Under 11 | $1.3M |
| Uttam G Reddy Orange, CA | Nephrology | 11 | Under 11 | $1.2M |
| Ewa Elenberg Houston, TX | Pediatric Medicine | 11 | Under 11 | $1.2M |
| Michelle Cornacchia Danville, PA | Internal Medicine | 12 | Under 11 | $1.1M |
| Paul E Walshaw Benson, AZ | Nephrology | 11 | Under 11 | $1.1M |
| Shahul H Valavoor Cincinnati, OH | Nephrology | 11 | Under 11 | $793K |
| Ladan Golestaneh New Haven, CT | Nephrology | 16 | Under 11 | $692K |
| Robert S Gillespie Fort Worth, TX | Nephrology | 12 | Under 11 | $692K |
| David W Clay Fayetteville, AR | Internal Medicine | 11 | Under 11 | $473K |
| Isaac Billings Polson, MT | Family Practice | 12 | Under 11 | $432K |
| Jignesh Shah Kansas City, MO | Nephrology | 24 | Under 11 | $173K |
| Manufacturer | Claims | Spending |
|---|---|---|
| Horizon/Amgen AMGN | 512 | $38.0M |